Brevitest Technologies
Jump to navigation
Jump to search
BREVITEST TECHNOLOGIES is developing a biomedical assay platform technology that could allow consumers, patients, caregivers, and others to more easily detect and quantify molecules of interest from a variety of sample types like blood, saliva, urine and water. This approach provides for a compact point-of-care diagnostics that is sensitive, specific and rapid. The BreviTest platform can be applied to a broad array of diagnostic tests, including those in emergency and non-emergency settings, allergen detection, home monitoring of chronic diseases as well as physiological conditions.
| Brevitest Technologies | |
|---|---|
| Startup Information | |
| Website | http://brevitest.com/ |
| Industry | |
| Accelerator | Fannin Innovation Studio |
| Accelerator (Other) | |
| Founder | |
| Founding Date | |
| Street Address | |
| City | |
| Zip Code | |
| Copyright © 2016 McNair Center. All Rights Reserved. | |
